デフォルト表紙
市場調査レポート
商品コード
1413242

ポイントオブケア&迅速診断市場:プラットフォーム、サンプル、購入、エンドユーザー別-2024-2030年の世界予測

Point of Care & Rapid Diagnostics Market by Platform (Dipstick, Immunoassay, Microfluidics), Sample (Blood, Urine), Purchase, End-User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.13円
ポイントオブケア&迅速診断市場:プラットフォーム、サンプル、購入、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポイントオブケア&迅速診断市場規模は2023年に484億3,000万米ドルと推計され、2024年には518億5,000万米ドルに達し、CAGR 7.11%で2030年には783億4,000万米ドルに達すると予測されます。

ポイントオブケア&迅速診断の世界市場

主な市場の統計
基準年[2023] 484億3,000万米ドル
予測年[2024] 518億5,000万米ドル
予測年 [2030] 783億4,000万米ドル
CAGR(%) 7.11%
Point of Care &Rapid Diagnostics Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはポイントオブケア&迅速診断市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、ポイントオブケア&迅速診断市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-ポイントオブケア&迅速診断市場の市場規模および予測は?

2-ポイントオブケア&迅速診断市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-ポイントオブケア&迅速診断市場における技術動向と規制の枠組みは?

4-ポイントオブケア&迅速診断市場における主要ベンダーの市場シェアは?

5-ポイントオブケア&迅速診断市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症の蔓延
      • 分散型ヘルスケアシステムの普及
      • 政府の支援政策
    • 抑制要因
      • 新しい迅速診断検査に対する認識の低下と標準的な規制手法の欠如
    • 機会
      • 多重化機能を備えた革新的なPOCテスト
    • 課題
      • 研究室での効果的な診断の代替方法
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ポイントオブケア&迅速診断市場:プラットフォーム別

  • ディップスティック
  • 免疫測定法
  • マイクロ流体工学

第7章 ポイントオブケア&迅速診断市場サンプル別

  • 尿

第8章 ポイントオブケア&迅速診断市場購入別

  • OTC
  • 処方箋

第9章 ポイントオブケア&迅速診断市場:エンドユーザー別

  • ホームケア
  • 病院
  • 薬局

第10章 南北アメリカのポイントオブケア&迅速診断市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のポイントオブケア&迅速診断市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのポイントオブケア&迅速診断市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Binx Health, inc.
    • bioMerieux SA
    • Cardinal Health, Inc.
    • Co-Diagnostics, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Genomadix Inc.
    • Lucira Health, Inc.
    • Meridian Bioscience Inc. by SD Biosensor
    • Novartis AG
    • OraSure Technologies, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
  • FIGURE 8. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 10. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2030 (%)
  • FIGURE 12. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIPSTICK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 10. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 13. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 188. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. POINT OF CARE & RAPID DIAGNOSTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-742BD5183A4F

[184 Pages Report] The Point of Care & Rapid Diagnostics Market size was estimated at USD 48.43 billion in 2023 and expected to reach USD 51.85 billion in 2024, at a CAGR 7.11% to reach USD 78.34 billion by 2030.

Global Point of Care & Rapid Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023] USD 48.43 billion
Estimated Year [2024] USD 51.85 billion
Forecast Year [2030] USD 78.34 billion
CAGR (%) 7.11%
Point of Care & Rapid Diagnostics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Point of Care & Rapid Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Point of Care & Rapid Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Point of Care & Rapid Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, inc., bioMerieux SA, Cardinal Health, Inc., Co-Diagnostics, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Genomadix Inc., Lucira Health, Inc., Meridian Bioscience Inc. by SD Biosensor, Novartis AG, OraSure Technologies, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Point of Care & Rapid Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Platform
    • Dipstick
    • Immunoassay
    • Microfluidics
  • Sample
    • Blood
    • Urine
  • Purchase
    • OTC
    • Prescription
  • End-User
    • Homecare
    • Hospital
    • Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Point of Care & Rapid Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Point of Care & Rapid Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Point of Care & Rapid Diagnostics Market?

4. What is the market share of the leading vendors in the Point of Care & Rapid Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Point of Care & Rapid Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Point of Care & Rapid Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High oprevelance of the infectious diseases
      • 5.1.1.2. Proliferation of decentralized healthcare systems
      • 5.1.1.3. Supportive government policies
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative POC test with multiplexing capabilities
    • 5.1.4. Challenges
      • 5.1.4.1. Alternate effective ways of diagnosis in laboratories
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Point of Care & Rapid Diagnostics Market, by Platform

  • 6.1. Introduction
  • 6.2. Dipstick
  • 6.3. Immunoassay
  • 6.4. Microfluidics

7. Point of Care & Rapid Diagnostics Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Urine

8. Point of Care & Rapid Diagnostics Market, by Purchase

  • 8.1. Introduction
  • 8.2. OTC
  • 8.3. Prescription

9. Point of Care & Rapid Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospital
  • 9.4. Pharmacy

10. Americas Point of Care & Rapid Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Point of Care & Rapid Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Point of Care & Rapid Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Becton, Dickinson and Company
    • 14.1.3. Binx Health, inc.
    • 14.1.4. bioMerieux SA
    • 14.1.5. Cardinal Health, Inc.
    • 14.1.6. Co-Diagnostics, Inc.
    • 14.1.7. Danaher Corporation
    • 14.1.8. F. Hoffmann-La Roche AG
    • 14.1.9. Genomadix Inc.
    • 14.1.10. Lucira Health, Inc.
    • 14.1.11. Meridian Bioscience Inc. by SD Biosensor
    • 14.1.12. Novartis AG
    • 14.1.13. OraSure Technologies, Inc.
    • 14.1.14. Siemens Healthineers AG
    • 14.1.15. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing